Abstract:Objective: To evaluate the role of diffusion-weighted MRI in differentiating benign from malignant primary bone tumors. To know the sensitivity and specificity of diffusion weighted MRI and calculating apparent diffusion coefficient (ADC) cutoff in differentiating benign from malignant primary bone tumors. Methods and materials : This is a prospective observational study of 50 patients, who were clinically or radiologically suspected with primary bone tumor and referred to the Department of Radiodiagnosis, for radiography or for MRI. These patients underwent routine MRI sequences including diffusion-weighted MRI with b-values of 0, 500 and 1000, followed by pathological examination supplemented by immunohistochemistry (wherever necessary). Hematological malignancies, recently biopsied cases and recurrent cases were excluded from the study. Results: Out of 50 patients with suspected bone tumors, 15 were benign (and tumor like lesions) and 35 were malignant primary bone tumors. The most common age group involved for both benign and malignant primary bone tumors was 11–20 years (23 cases—46%). In our study, total number of affected males were 27 (54%) and total number of affected females were 23 (46%) with M:F ratio of 1.17:1. In this study 72% lesions had appendicular bone involvement and 28% had axial bone involvement. 94.3% of malignant lesions showed restriction on diffusion-weighted imaging (DWI) and in 80 % of benign lesions restriction was absent on DWI which was statistically significant. Mean ADC levels in malignant lesions was 1.092 ± 0.497 and in benign lesions was 1.62 ± 0.596 which was statistically significant. Chondrosarcoma had highest ADC and Ewing’s sarcoma had lowest ADC values in malignant lesions. Chondroblastoma had highest ADC and Osteomyelitis had lowest ADC values in benign lesions. ADC value of 1.31 had highest sensitivity and specificity to differentiate between benign and malignant lesions. Conclusion: DWI is helpful in differentiating malignant from benign bone tumors and tumor like lesions with diffusion restriction favoring malignancy. Inspite of some overlap, ADC values of benign and malignant bone tumors are different and measurement of ADC values improves the accuracy of the diagnosis of bone tumors and tumor like lesions. Calculation of ADC may also be used as baseline reference to assess response to treatment in future or for follow up. Advances in knowledge: DWI imaging (and ADC values) has been extensively used in neuroimaging. Extension of this application to musculoskeletal–oncologic imaging is not so well studied. Apart from differentiating benign from malignant lesions which is the main focus of this study, assessment of response to treatment by ADC values may be possible in near future.

Role of apparent diffusion coefficients with diffusion-weighted magnetic resonance imaging in differentiating between benign and malignant bone tumors

Diffusion Weighted Imaging and Apparent Diffusion Coefficient Value in Differential Diagnosis of Lymph Node Lesions

Role of diffusion-weighted MRI in differentiating benign from malignant bone tumors

Value of Apparent Diffusion Coefficient in MR Diffusion-Weighted Imaging for Differential Diagnosis of Benign and Malignant Musculoskeletal Tumors

Correlation Between Magnetic Resonance Diffusion Weighted Imaging and Pathology in Lymphoma

Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI

The differential diagnosis of malignant and benign bladder neoplasm using diffusion-weighted MR imaging

Predictive Ability of DWI/ADC and DCE-MRI Kinetic Parameters in Differentiating Benign from Malignant Breast Lesions and in Building a Prediction Model.

Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging

A Preliminary Study on Distinguishing Pulmonary Malignant Tumors from Solid Benign Lesions by Diffusion-weighted Imaging

Optimization of Apparent Diffusion Coefficient Measured by Diffusion-Weighted MRI for Diagnosis of Breast Lesions Presenting As Mass and Non-Mass-like Enhancement

Correlating Apparent Diffusion Coefficients with Histopathologic Findings on Meningiomas

Apparent diffusion coefficient measurements of bone marrow infiltration patterns in multiple myeloma for the assessment of tumor burden – a feasibility study

Diagnostic Value of Whole-Body DWI with Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus 18F-FDG PET/CT for Detection of Bone Metastases

Diagnostic Accuracy of Diffusion-Weighted Imaging with Conventional MR Imaging for Differentiating Complex Solid and Cystic Ovarian Tumors at 1.5T

Differentiation of Clinically Benign and Malignant Breast Lesions Using Diffusion-Weighted Imaging

Application of Diffusion-Weighted Imaging for the Differential Diagnosis of Soft-Tissue Tumors

Characterization of Breast Masses As Benign or Malignant at 3.0t Mri with Whole-Lesion Histogram Analysis of the Apparent Diffusion Coefficient

Value of MRI in-phase and opposed-phase,apparent diffusion coefficient and diffusion-weighted imaging in distinguishing benign and malignant spinal lesions

ADC Values in Differentiation of Benign and Malignant Thyroid Nodules

Utility of Diffusion-Weighted Imaging in Differentiating Malignant from Benign Thyroid Nodules with Magnetic Resonance Imaging and Pathologic Correlation